We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
+4.67%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$75.1B
AUM Growth
+$5.64B
(+8.1%)
Cap. Flow
+$2.6B
Cap. Flow
% of AUM
3.46%
Top 10 Holdings %
Top 10 Hldgs %
45.24%
Holding
2,898
New
250
Increased
1,458
Reduced
767
Closed
254
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$495M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$421M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$294M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$274M |
| 5 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$117M |
| 2 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$51.7M |
| 3 |
Alerian MLP ETF
AMLP
|
+$25.9M |
| 4 |
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
|
+$21.3M |
| 5 |
Vanguard High Dividend Yield ETF
VYM
|
+$20.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.17% |
| 2 | Financials | 2.88% |
| 3 | Consumer Discretionary | 1.69% |
| 4 | Healthcare | 1.58% |
| 5 | Consumer Staples | 1.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Galectin Therapeutics
GALT
$229M
| $30.3K | ﹤0.01% |
21,048
| – | – |
|
2477
Companhia Siderúrgica Nacional
SID
$1.43B
| $30.3K | ﹤0.01% |
11,681
+244
| +2% | +$672 |
|
2478
Douglas Elliman
DOUG
$155M
| $30.1K | ﹤0.01% |
13,551
-2,061
| -13% | -$5.66K |
|
2479
Xeris Biopharma Holdings
XERS
$1.44B
| $29.9K | ﹤0.01% |
+11,393
| New | +$29K |
|
2480
CALL
Costco
COST
$415B
| $29.5K | ﹤0.01% |
100
| – | – |
|
2481
CALL
QuantumScape Corp
QS
$3B
| $29.2K | ﹤0.01% |
11,900
+5,900
| +98% | +$41K |
|
2482
Gevo
GEVO
$397M
| $28.9K | ﹤0.01% |
19,009
+1,855
| +11% | +$2.4K |
|
|
AEY
2483
DELISTED
ADDvantage Technologies Group
AEY
| $28.3K | ﹤0.01% |
4,563
+2,021
| +80% | +$16.2K |
|
2484
Fossil Group
FOSL
$239M
| $28.1K | ﹤0.01% |
10,932
+230
| +2% | +$632 |
|
|
TGB
2485
Trekor Metals
TGB
$2.56B
| $27.9K | ﹤0.01% |
19,529
+4,610
| +31% | +$6.9K |
|
2486
CALL
Carnival Corporation Ltd
CCL
$36.1B
| $26.4K | ﹤0.01% |
+5,000
| New | +$58.5K |
|
2487
American Well
AMWL
$181M
| $26.2K | ﹤0.01% |
624
-338
| -35% | -$14.9K |
|
2488
Cerus
CERS
$587M
| $25.5K | ﹤0.01% |
+10,382
| New | +$24.7K |
|
2489
Grupo Aval
AVAL
$5.67B
| $25.4K | ﹤0.01% |
10,939
-6,358
| -37% | -$15.2K |
|
|
PSTX
2490
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $23.9K | ﹤0.01% |
13,600
+1,000
| +8% | +$2.55K |
|
2491
Globalstar
GSAT
$10.2B
| $23.8K | ﹤0.01% |
1,466
-150
| -9% | -$2.4K |
|
|
CTEV
2492
Claritev Corp
CTEV
$368M
| $23.7K | ﹤0.01% |
280
-289
| -51% | -$15.4K |
|
|
GMDA
2493
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $23.4K | ﹤0.01% |
+12,138
| New | +$20.9K |
|
|
BLRX
2494
BioLineRX
BLRX
$12.3M
| $23.3K | ﹤0.01% |
365
| – | – |
|
|
OTLY
2495
Oatly Group
OTLY
$417M
| $23.2K | ﹤0.01% |
566
-16
| -3% | -$654 |
|
2496
CALL
JPMorgan Chase
JPM
$939B
| $22.7K | ﹤0.01% |
300
| – | – |
|
2497
American Resources Corp
AREC
$186M
| $22.5K | ﹤0.01% |
11,500
| – | – |
|
2498
bioAffinity Technologies
BIAF
$4.15M
| $22.1K | ﹤0.01% |
403
| – | – |
|
|
NEWP
2499
New Pacific Metals
NEWP
$833M
| $21.8K | ﹤0.01% |
+10,015
| New | +$24.5K |
|
2500
Coeur Mining
CDE
$15.6B
| $20.9K | ﹤0.01% |
+7,364
| New | +$25K |
|
Similar funds
Creative Planning's Q2 2023 Portfolio in Review
As of Q2 2023, Creative Planning held 2,898 positions worth $75.1B, up 8.1% from $69.4B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Creative Planning deployed $2.6B of net new capital in Q2 2023, opening 250 new positions and adding to 1,458 existing holdings. Its largest new stake was United Homes Group: 388,000 shares worth $4.33M.
By sector, the portfolio is most concentrated in Technology at 5.2% of assets, up from 4.7% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $117M trimmed.
- Creative Planning's largest Q2 2023 buy was United Homes Group: 388,000 shares worth $4.33M.
- Creative Planning added most to Vanguard Total Bond Market in Q2 2023, an estimated $495M increase.
- Creative Planning's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $117M.
- Creative Planning fully exited PIMCO 15+ Year US TIPS Index Exchange-Traded Fund in Q2 2023, selling an estimated $2.75M.
- Creative Planning's ten largest holdings make up 45% of its $75.1B portfolio in Q2 2023.
- Creative Planning opened 250 new positions and closed 254 in Q2 2023.
- Creative Planning's portfolio value rose 8.1% quarter-over-quarter to $75.1B.
Based on Creative Planning's 13F filing for Q2 2023, filed 21 Jul 2023.